![](https://aclipsetherapeutics.com/wp-content/uploads/2023/10/AdobeStock_118852399-scaled.jpeg)
Aclipse Therapeutics Expands Drug Development Pipeline
Aclipse Therapeutics Expands Drug Development Pipeline with Signing of Exclusive, Worldwide License Agreement with Chong Kun Dang Pharmaceutical Corporation to Develop Potential Disease-Modifying Treatment for